Aflac Incorporated (AFL) is a Healthcare stock trading at $118.20 (as of 2026-08-24), with a market capitalization of $60.16B and a trailing P/E of 13.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Aflac Incorporated, through its subsidiaries, offers supplemental health and life insurance products. It operates in Aflac Japan and Aflac U.S., providing products such as cancer, medical, nursing care income, and life and savings-type plans in Japan, and a range of health and life coverages in the United States sold via sales associates, brokers, independent corporate and individual agencies, and affiliated corporate agencies.
Aflac provides supplemental health and life insurance products in Japan and the United States, making money by collecting premiums from policyholders.
Aflac earns from insurance premiums and investment income, while claims and operating expenses are the main costs that determine profit.
Business quality (Solid): Solid, with strong profitability but modest top-line contraction.
Valuation: At 13× earnings, AFL trades in line with the Insurance average (13×).
| Price | $118.20 |
| Market Cap | $60.16B |
| P/E Ratio | 13.4 |
| EV / EBITDA | 9.9 |
| Price / Book | 1.98 |
| Price / Sales | 3.43 |
| DCF Value (model) | $103.33 |
| DCF Upside vs Price | -12.6% |
| Revenue (TTM) | $17.16B |
| Net Margin | 21.2% |
| Revenue Growth (YoY) | -9.3% |
| EPS Growth (YoY) | -29.3% |
| Stock P/E | 13.4 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Insurance) | 13.1 |
| vs Sector | -38.4% |
| vs Industry | 2.3% |
| Top Institutional Holder | VANGUARD GROUP INC ($6.30B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 8 |
| Sector | Healthcare |
| Industry | Insurance |
| CEO | Daniel Paul Amos |
| Employees | 12,694 |
| Country | US |
| IPO Date | 1980-03-17 |
Data as of 2026-08-24.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.